scorecardresearch
Add as a preferred source on Google
Saturday, April 18, 2026
TopicPharma sector

Topic: Pharma sector

To ease launch of generics & push clinical trials of novel therapies, govt moves to amend drug rules

Proposed amendments to New Drugs and Clinical Trial Rules will scrap test licences, cut application processing time. Move part of govt effort to establish India as hub for pharma R&D.

India ceding ground in biopharma innovation, manufacturing — AllianceBernstein’s open letter to PM

Analysts from AllianceBernstein point to four areas where India lags behind its Asian peers and underline that nation finds no mention in global healthcare innovation index.

Cheap alternatives, API imports — why Penicillin G production, set to resume after 30 yrs, declined

Production of PenG, used to treat tetanus, strep infections, syphilis, pneumonia & more, was stopped in India in 1990s after cheaper alternatives began surfacing in global market.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Trade body says Indian pharma exports to hit $27 billion this fiscal, despite cough syrup deaths

India is the world's third largest maker of drugs by volume, and US sales, which account for 30% of total pharma exports, have risen by 6.2% last year.

Una’s bulk drug park is the ‘next Bhakra Nangal’. And it’s BJP’s trump card in Himachal polls

In the homes of BJP supporters, photocopies of the map of the land demarcated for the bulk drug park are doing the rounds.

Haryana firm flagged by WHO after 66 child deaths in Gambia stops making ‘contaminated’ syrups

After an inspection, the Haryana government finds 12 flaws in the manufacturing facility; ‘Action will be taken,’ says Home and Health Minister Anil Vij.

Cough syrups made by Delhi-based Maiden Pharma may be tied to 66 deaths in Gambia, says WHO

In July, alarm was raised in Gambia after several children began falling ill with kidney problems. WHO has issued an alert asking regulators to remove the company's goods from the market.

Apollo, Reliance make $6.3-billion binding offer to buy UK drugstore chain Boots

Walgreens Boots Alliance’s negotiations with Apollo and Reliance currently have the most momentum, said people in the know. Their proposal values Boots at more than £5 billion ($6.3 billion).

Ireland ‘exploring’ tie-up with DU to build bridges in higher education, research collaboration

Conor Fahy of govt agency Enterprise Ireland says such collaboration can ‘deepen FDI’. DU V-C Yogesh Singh says MoU with Irish varsities likely by end of 2022.

On Camera

The math behind India’s elections—Why proximity matters

It is one of the most consistent findings in electoral politics: voters are more likely to support candidates who come from their local area.

US ends oil waivers but Russian crude flows to India ‘likely to remain steady’ amid Hormuz disruption

India will need to recalibrate crude sourcing strategy as US ends waivers for Russian & Iranian oil, energy experts say. But Russian crude will likely remain central to energy basket.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

The world’s in a flux. India must reform, consolidate & build a strong economy

We now live in a world order that will keep shifting. India must use this window. This also means we remain disciplined enough not to be knee-jerked into reacting to what Pakistan sees as its moment in the sun.